Inorganic synthetic NPs was engineered to encapsulate miR-145 using PAMAM dendrimers modified with a thioaptamer (TA), a protein that binds CD44—receptors highly expressed on BC cells [38]. The gene discussed is CD44; the disease is breast cancer.